GlaxoSmithKline has decided that stopping distribution of its Zantac products just won’t cut it. The U.K. company has decided it is time to pull its ranitidine heartburn meds off the shelves in markets where it sells them.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,